drugset / Trial / NCT00105586

Drug Therapy for Generalized Anxiety Disorder Among the Elderly

NCT00105586 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will determine the efficacy of escitalopram (Lexapro®), an anti-anxiety drug, for generalized anxiety disorder (GAD) and the ways genetics affect response to treatment for GAD in elderly individuals.

Timeline

Start
2004-12
Primary completion
2008-01
Completion
2008-04

Outcome

Met primary endpoint

paper response rate for escitalopram was 69% (95% confidence interval [CI], 58%-80%) vs 51% (95% CI, 40%-62%) for placebo (P = .03). PMID 19155456 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 10 mg —
Subject Escitalopram Small molecule 20 mg —